Author

Jean–Michel Pawlotsky

InsermORCID 0000-0003-0745-7559Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

Abdelhakim Ahmed‐BelkacemiD· 1 shared Alexandre BancetiD· 1 shared Angélique MularoniiD· 1 shared Bryan Jimenez-ArayaiD· 1 shared Christophe RodrigueziD· 1 shared Cyril PlanchaisiD· 1 shared D. Grenier· 1 shared Delphine PlanasiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abdelhakim Ahmed‐BelkacemORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 5, 2026

Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses

Dennis Salomon Lopez Molina, Nazim Ahnou, Rozenn Brillet…·Abdelhakim Ahmed‐Belkacem

This study identifies CK2 as a critical host factor for SARS-CoV-2 replication and shows that the bivalent inhibitor AB668 effectively inhibits multiple coronaviruses.

DOI 10.64898/2026.10.05.756735

humanexperimental assay

𝕏 PostBluesky

MicrobiologyJournal of VirologyPeer-reviewedDec 13, 2023

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

William Bolland, Vincent Michel, Delphine Planas…·Julian Buchrieser

This study characterizes the high fusogenicity and cytopathic effects of the SARS-CoV-2 B.1.640.1 variant, identifying mutations in the spike S2 domain responsible for these properties.

8 citations

humanproteomics

𝕏 PostBluesky